Get started
Author

Umesh S. Shaligram

Observed names: Shaligram, Umesh, U. Shaligram, UMESH SHALIGRAM, Umesh Shaligram
Observed institutions: Serum Institute of India (India), University of Oxford, NIHR Oxford Biomedical Research Centre, Jenner Institute, Novavax (Sweden), Institut de Recherche en Sciences de la Santé, Indian Institute of Science Bangalore
ORCID: 0000-0002-2301-2595
Observed ORCID: 0000-0002-2301-2595
OpenAlex ID: A5072784089
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
2021 · Mehreen S Datoo, Magloire H Natama, et al. · The Lancet · 501
PDF
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
2024 · Mehreen S Datoo, Alassane Dicko, et al. · The Lancet · 450
PDF
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trial
2022 · Mehreen S Datoo, Hamtandi Magloire Natama, et al. · The Lancet Infectious Diseases · 300
The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
2017 · Natalie E. Nieuwenhuizen, Prasad S. Kulkarni, et al. · Frontiers in Immunology · 204
PDF
Simple repetitive sequences in the genome: Structure and functional significance
1995 · Samir K. Brahmachari, Gopinath Meera, et al. · Electrophoresis · 114
Safety and immunogenicity of VPM1002 versus BCG in South African newborn babies: a randomised, phase 2 non-inferiority double-blind controlled trial
2022 · Mark F Cotton, Shabir A Madhi, et al. · The Lancet Infectious Diseases · 84
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
2024 · Hamtandi M Natama, Jo Salkeld, et al. · The Lancet Infectious Diseases · 58
PDF
Challenge studies in Rhesus monkeys immunized with candidate hepatitis E vaccines: DNA, DNA-prime-protein-boost and DNA-protein encapsulated in liposomes
2008 · Vidya A. Arankalle, Kavita S. Lole, et al. · Vaccine · 54
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
2023 · Hitt Sharma, Sameer Parekh, et al. · The Lancet Oncology · 53
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study
2022 · Alexandra M Blossey, Sina Brückner, et al. · Clinical Infectious Diseases · 37
PDF
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India
2021 · Prasad S Kulkarni, Chandrasekaran Padmapriyadarsini, et al. · EClinicalMedicine · 36
PDF
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
2020 · Cyrill A. Rentsch, Piet Bosshard, et al. · OncoImmunology · 35
PDF
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques
2022 · Neil C. Dalvie, Lisa H. Tostanoski, et al. · Science Advances · 32
PDF
Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii
2021 · Neil C. Dalvie, Andrew M. Biedermann, et al. · Biotechnology and Bioengineering · 29
PDF
Development of candidate combination vaccine for hepatitis E and hepatitis B: A liposome encapsulation approach
2009 · Shubham Shrivastava, Kavita S. Lole, et al. · Vaccine · 25
The 100 Days Mission: how a new medical-countermeasures network can deliver equity and innovation
2023 · Victor Dzau, Soumya Swaminathan, et al. · The Lancet · 21
The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India
2022 · Saurabh Attarde, Ashwin Iyer, et al. · Toxins · 17
PDF
Clinical Application of Polysialylated Deoxyribonuclease and Erythropoietin
2018 · He Meng, Sanjay Jain, et al. · Recent Patents on Drug Delivery & Formulation · 17
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin
2023 · Vishal Rathod, Laxmikant Kadam, et al. · Frontiers in Immunology · 15
High Efficacy of a Low Dose Candidate Malaria Vaccine, R21 in 1 Adjuvant Matrix-M™, with Seasonal Administration to Children in Burkina Faso
2021 · Mehreen S. Datoo, Hamtandi Magloire Natama, et al. · SSRN Electronic Journal · 15
Complete Genome Sequences of Four Bordetella pertussis Vaccine Reference Strains from Serum Institute of India
2016 · Michael R. Weigand, Yanhui Peng, et al. · Genome Announcements · 14
PDF
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
2023 · Prasad S. Kulkarni, Abhijit Kadam, et al. · The Lancet Regional Health - Southeast Asia · 13
Analytical and Preformulation Characterization Studies of Human Papillomavirus Virus-Like Particles to Enable Quadrivalent Multi-Dose Vaccine Formulation Development
2022 · Kaushal Jerajani, Ying Wan, et al. · Journal of Pharmaceutical Sciences · 13
Comparative genomics of whole-cell pertussis vaccine strains from India
2020 · Shweta Alai, Vikas C. Ghattargi, et al. · BMC Genomics · 13
PDF
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial
2023 · Bhagwat Gunale, Dhananjay Kapse, et al. · Archives of Pediatrics and Adolescent Medicine · 12
PDF
Works count: 66
Citation count: 2,273
H-index: 17
I10-index: 27
Year
Topic
Type